Evidence map›Paper›PMID 42827468›Full record

ArticleFrontiers in urology2026

Radiomic model versus R.E.N.A.L. nephrometry score for predicting the likelihood of undergoing partial nephrectomy in clear cell renal cell carcinoma.

Fa-de Liu, Hui-Li Yu, Du-Jian Wang, Xiao-Bing Ju, Yan-Hao Yang

Abstract read
In one paragraph

Article in Frontiers in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fa-de Liu *Department of Urology, Jiangning Clinical Medical College of Kangda College of Nanjing Medical University, Nanjing, Jiangsu, China.
Hui-Li Yu *Department of Urology, Jiangning Clinical Medical College of Kangda College of Nanjing Medical University, Nanjing, Jiangsu, China.
Du-Jian Wang *Department of Urology, Jiangning Clinical Medical College of Kangda College of Nanjing Medical University, Nanjing, Jiangsu, China.
Xiao-Bing JuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Yan-Hao YangDepartment of Urology, Jiangning Clinical Medical College of Kangda College of Nanjing Medical University, Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To develop a CT-based radiomic model for predicting partial nephrectomy (PN) in clear cell renal cell carcinoma (ccRCC) and compare it with the R.E.N.A.L. Nephrometry Score (RNS). Methods: This retrospective study included 413 ccRCC patients who underwent PN or radical nephrectomy. The RNS was calculated from preoperative CT. Radiomic features were extracted from corticomedullary-phase CT. Reproducibility was assessed using intraclass correlation coefficients (ICCs). LASSO regression was used for feature selection and Rad-score construction. Multivariable logistic regression models were built based on the total RNS sum and the Rad-score. Performance was evaluated by AUC, calibration, and decision curve analysis. Results: Of 1210 extracted features (after excluding general_info fields), 851 showed good to excellent reproducibility (ICC > 0.75). The radiomic model (6 selected features) achieved an AUC of 0.886 (95% CI: 0.81-0.91) in the internal validation cohort, significantly outperforming the RNS model (AUC = 0.793, 95% CI: 0.72-0.85; DeLong test, P = 0.015). The radiomic model also demonstrated better calibration (Brier score: 0.11 vs. 0.16) and higher clinical net benefit. SHAP analysis identified tumor size and texture heterogeneity as the strongest predictors. Conclusion: A CT-based radiomic model provides superior accuracy over the RNS for preoperatively predicting PN likelihood in ccRCC and holds significant potential to augment surgical decision-making and personalize treatment planning. Prospective multi-center validation is warranted before routine clinical adoption.

Indexed as

carcinomamachine learningnephrectomynephrometry scoreradiomicsrenal celltomography

Identifiers

PMID42827468
PMCPMC13630628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.